MetaCap

BIO-key International Stock Forecast

NASDAQ: BKYITechnologyComputer Software: Prepackaged SoftwareUSD

1.67-0.07 (-4.02%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

BKYI analyst consensus

Consensus (1 analysts)

none

Avg. price target

$20.00+1097.60%

  • Strong buy 1
  • Buy 0
  • Hold 0
  • Sell 0
  • Strong sell 0

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

What analysts say

According to 1 Wall Street analyst covering BIO-key International (2026-10-09), 1 rate the stock a buy or strong buy, 0 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "none". The average 12-month price target is $20.00, with a high estimate of $20.00 and a low estimate of $20.00. The average target implies upside of 1097.6% from the current price of $1.67.

The spread between the highest and lowest targets is 0.0%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for BKYI.

Summary generated from market data by MetaCap's automated system. Methodology

Rating distribution

BIO-key International analyst rating distribution
RatingAnalystsShare
Strong buy1100%
Buy00%
Hold00%
Sell00%
Strong sell00%

Ratings as of 2026-10-09.

Price target scenarios

Price targets versus the current price
TargetPricevs. current
Low target$20.00+1097.60%
Average target$20.00+1097.60%
High target$20.00+1097.60%

How analysts view BIO-key International's peers

Peer analyst targets
CompanyConsensusPriceAvg. targetImplied move
FRSXnone0.8502$4.00+370.48%

Related